Descriptor English: | Cyclic Nucleotide Phosphodiesterases, Type 5 | ||||
Descriptor Spanish: |
Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5
| ||||
Descriptor Portuguese: | Nucleotídeo Cíclico Fosfodiesterase do Tipo 5 | ||||
Descriptor French: | Cyclic Nucleotide Phosphodiesterases, Type 5 | ||||
Entry term(s): |
PDE5 Phosphodiesterases Phosphodiesterase 5 Phosphodiesterase 5A Phosphodiesterase 5A, cGMP Specific Phosphodiesterase 5A, cGMP-Specific Phosphodiesterase Type 5 Phosphodiesterase Type V Phosphodiesterase V Phosphodiesterase-5 Phosphodiesterases, PDE5 Type 5, Phosphodiesterase Type V, Phosphodiesterase cGMP-Binding, cGMP-Specific 3',5'-cyclic Nucleotide Phosphodiesterase cGMP-Specific Phosphodiesterase 5A |
||||
Tree number(s): |
D08.811.277.352.640.150.500 D08.811.277.352.640.155.500 D12.776.476.008.500 D12.776.476.009.500 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D054706 | ||||
Scope note: | A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC GMP. It is found predominantly in vascular tissue and plays an important role in regulating VASCULAR SMOOTH MUSCLE contraction. |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Entry Combination: |
antagonists & inhibitors:Phosphodiesterase 5 Inhibitors
|
||||
Registry Number: | EC 3.1.4.35 | ||||
Public MeSH Note: | 2008; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5 was indexed under 3',5'-CYCLIC-GMP PHOSPHODIESTERASE 1998-2007 |
||||
History Note: | 2008(1998) |
||||
DeCS ID: | 52680 | ||||
Unique ID: | D054706 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2008/01/01 | ||||
Date of Entry: | 2007/07/09 | ||||
Revision Date: | 2016/04/15 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Cyclic Nucleotide Phosphodiesterases, Type 5
- Preferred
Concept UI |
M0295388 |
Scope note | A cyclic nucleotide phosphodiesterase subfamily that is highly specific for CYCLIC GMP. It is found predominantly in vascular tissue and plays an important role in regulating VASCULAR SMOOTH MUSCLE contraction. |
Preferred term | Cyclic Nucleotide Phosphodiesterases, Type 5 |
Entry term(s) |
PDE5 Phosphodiesterases Phosphodiesterase 5 Phosphodiesterase 5A Phosphodiesterase 5A, cGMP Specific Phosphodiesterase 5A, cGMP-Specific Phosphodiesterase Type 5 Phosphodiesterase Type V Phosphodiesterase V Phosphodiesterase-5 Phosphodiesterases, PDE5 Type 5, Phosphodiesterase Type V, Phosphodiesterase cGMP-Binding, cGMP-Specific 3',5'-cyclic Nucleotide Phosphodiesterase cGMP-Specific Phosphodiesterase 5A |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey